123 related articles for article (PubMed ID: 32325347)
1. LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/ERK pathway.
Li J; Hu S; Zhang Z; Qian L; Xue Q; Qu X
Biomed Pharmacother; 2020 Jul; 127():110154. PubMed ID: 32325347
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LASP2 inhibits the proliferation, migration, and invasion of cervical cancer cells.
Zhang Y; Zhang L
J Cell Biochem; 2019 Sep; 120(9):15389-15396. PubMed ID: 31026088
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF-β-induced EMT.
Zhang Y; Li JH; Yuan QG; Cao G; Yang WB
J Cell Biochem; 2019 Aug; 120(8):13651-13657. PubMed ID: 30945341
[TBL] [Abstract][Full Text] [Related]
4. 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells.
Ai HH; Zhou ZL; Sun LG; Yang MT; Li W; Yu CL; Song ZB; Huang YX; Wu Y; Liu L; Yang XG; Zhao YQ; Bao YL; Li YX
Apoptosis; 2017 Nov; 22(11):1404-1418. PubMed ID: 28864870
[TBL] [Abstract][Full Text] [Related]
5. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
[TBL] [Abstract][Full Text] [Related]
6. LASP2 inhibits trophoblast cell migration and invasion in preeclampsia through inactivation of the Wnt/β-catenin signaling pathway.
Chen L; Wang J; Fan X; Zhang Y; Zhoua M; Li X; Wang L
J Recept Signal Transduct Res; 2021 Feb; 41(1):67-73. PubMed ID: 32635793
[TBL] [Abstract][Full Text] [Related]
7. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
9. LASP2 functions as a potential prognostic factor and therapeutic target in nasopharyngeal carcinoma.
Yang YT; Nie LM; Wei QF; Li WZ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9416-9422. PubMed ID: 33015783
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of calycopterin via PI3K/Akt and MAPK signaling pathways, ROS-mediated pathway and mitochondrial dysfunction in hepatoblastoma cancer (HepG2) cells.
Esmaeili MA; Farimani MM; Kiaei M
Mol Cell Biochem; 2014 Dec; 397(1-2):17-31. PubMed ID: 25060910
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
[TBL] [Abstract][Full Text] [Related]
12. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of hepatic lipase is associated with decreased CD133 expression and clone formation in HepG2 cells.
Liu X; Zuo J; Fang Y; Wen J; Deng F; Zhong H; Jiang B; Wang J; Nie B
Int J Mol Med; 2018 Oct; 42(4):2137-2144. PubMed ID: 30015857
[TBL] [Abstract][Full Text] [Related]
15. Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K/Akt and MAPK signaling pathways.
Mi Y; Xiao C; Du Q; Wu W; Qi G; Liu X
Free Radic Biol Med; 2016 Jan; 90():230-42. PubMed ID: 26593748
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
Hsiao CC; Kao YH; Huang SC; Chuang JH
Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
[TBL] [Abstract][Full Text] [Related]
17. Single-walled carbon nanohorn aggregates promotes mitochondrial dysfunction-induced apoptosis in hepatoblastoma cells by targeting SIRT3.
Li B; Chen X; Yang W; He J; He K; Xia Z; Zhang J; Xiang G
Int J Oncol; 2018 Sep; 53(3):1129-1137. PubMed ID: 29956732
[TBL] [Abstract][Full Text] [Related]
18. Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.
Liu W; Zhang Q; Tang Q; Hu C; Huang J; Liu Y; Lu Y; Wang Q; Li G; Zhang R
Oncol Rep; 2018 Oct; 40(4):2298-2306. PubMed ID: 30066939
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids of Korean Citrus aurantium L. Induce Apoptosis via Intrinsic Pathway in Human Hepatoblastoma HepG2 Cells.
Lee SH; Yumnam S; Hong GE; Raha S; Saralamma VV; Lee HJ; Heo JD; Lee SJ; Lee WS; Kim EH; Park HS; Kim GS
Phytother Res; 2015 Dec; 29(12):1940-9. PubMed ID: 26439681
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
